Frank Moriarty

This role would be a good fit for an experienced postdoctoral researcher interested in deprescribing, medication appropriateness, and healthcare data.

@deprescribing.bsky.social @deprescribeus.bsky.social @caden-recad.bsky.social

Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing.

More information about the DIAMOND programme available at: diamond-deprescribing.eu

Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...

A conference exploring how clinical research, medication safety and patient empowerment could impact national initiatives to support ageing adults took place in Dublin today, organised by @rcsipophealth.bsky.social and @tcddublin.bsky.social

#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience

We work on developing methods to better support research on deprescribing and to ultimately improve medicines optimisation.

You can find out more about the DIAMOND research programme on our website or LinkedIn profile:
diamond-deprescribing.eu
www.linkedin.com/company/diamond-derx/

Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social!

If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...

This early access original research study identifies five clinically relevant prescribing cascades in a national sample of more than half a million older adults in Ireland. #FMsky#Medsky #PrimaryCare

www.annfammed.org/content/earl...

Should the maker of Ozempic be funding children’s playgrounds in Ireland? In 2023, Novo Nordisk was suspended by its own industry body in the UK for two years over its sponsorship of weight management courses for health professionals

On Saturday, the Irish Times published a piece I wrote asking whether Novo Nordisk should be funding children’s playgrounds.

We need to ask if there are hidden costs to Novo Nordisk funding parts of our education and health systems, costs that may not be worth paying for.

shorturl.at/erwpH

Well done to WP lead Ryan Muddiman & review co-authors: Florencia Ines Aiello Battan, John Tazare, @annaschultze.bsky.social, Teresa Perez, Li Wei, @fionaboland.bsky.social, @marywalsh14.bsky.social @frankmoriarty.bsky.social #CausalInference #Deprescribing #DIAMOND diamond-deprescribing.eu

Pharmacoepidemiology simulation study practices: A methodological review Purpose Simulation studies are used in pharmacoepidemiology for evaluating inferential methods in a controlled setting, whereby a known data-generating mechanism allows evaluation of the performance o...

DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025....
We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining

Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!

Modelling the impact of changes to prescription medicine cost-sharing schemes among middle aged and older adults To assess impacts of government changes to prescription medicine co-payments on individuals’ out-of-pocket expenditure.Participants were community-dwe…

Publication: We modelled the impact of post-2016 changes to prescription medicine co-payment charges and cost caps on out-of-pocket prescription expenditure

Mean annual expenditure for medical card holders reduced from €117 to €55. For the DPS-group, it reduced from €719 to €555

shorturl.at/l7OAh

Enhancing prescribing In chronic kidney disease in primary care (EPIC) The overall research project aims to develop a comprehensive set of indicators to guide medicines optimisation and deprescribing in people with CKD in primary care. More ...

We're looking for a PhD scholar for a @hrbireland.bsky.social funded 4-year project focused on prescribing and deprescribing in chronic kidney disease, based at @rcsi.bsky.social.

If interested in pharmacoepi/health services research, please apply (D/L 2nd June): www.rcsi.com/dublin/resea...

Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in: 
📈 Biostatistics & Data Science 
🏥 Health Services Research & GP
💊 Pharmacy & Pharmacoepidemiology 
🗣️ Patient & Public Involvement
Details here: diamond-deprescribing.eu/team/. #HopefulFutures

Excited to be part of this innovative programme of work @rcsi.bsky.social led by my long-time colleague @frankmoriarty.bsky.social. It has the potential to transform #bigdata research in this field, making it transparent and reproducible, informing challenging clinical decisions globally! 🌍 #DIAMOND

We're officially launching the DIAMOND research programme today, hosted by @rcsi.bsky.social.

Our research focuses on #deprescribing and #bigdata, check out our website below for more information and follow for updates 👇

Planning for ICOD3 has launched! 🚀

The ICOD3 planning committee met for the 1st time to brainstorm vision & objectives for the meeting, to be held in Spring 2026 in Canada and co-hosted by CADeN & @deprescribeus.bsky.social.

Stay tuned for more info: official dates and venue are coming soon! 👀

Many thanks to the other study team members @shellflood.bsky.social, Ciara Kirke, Molly Mattsson, @marywalsh14.bsky.social, @profemmawallace.bsky.social, Derek Corrigan, Tom Fahey, and Fiona Boland.

RxTrends uses data released by the Primary Care Reimbursement Service on the top 100 medicines per month for the GMS (medical card) scheme. We are hoping to expand the functionality more in the future, however this needs more #opendata to be made available.

Very pleased to launch RxTrends, a tool to visualise open data on medication prescribing in Ireland: cdrx-project.eu/rxtrends/.

It was developed by Dr Ahmed Hassan Ali as part of the HRB-funded CDRx project. You can read more about the tool in the companion paper: hrbopenresearch.org/articles/8-36

Huge congratulations Dr Hughes! Enjoy the celebrations.

A bit late to the game!